Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001010451 | SCV001170651 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-02-29 | criteria provided, single submitter | clinical testing | The c.1230_1232delCATinsTG pathogenic mutation, located in coding exon 12 of the MLH1 gene, results from the deletion of three nucleotides and insertion of two nucleotides causing a translational frameshift with a predicted alternate stop codon (p.I411Vfs*80). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Ding PR Lab, |
RCV001093672 | SCV001250853 | likely pathogenic | Lynch syndrome 1 | no assertion criteria provided | clinical testing |